Vir Biotechnology, Inc. (VIR)
USD 5.45
(3.13%)
USD 5.45
(3.13%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -615.06 Million USD | -219.24% |
| 2022 | 515.83 Million USD | -2.41% |
| 2021 | 528.58 Million USD | 276.98% |
| 2020 | -298.66 Million USD | -70.98% |
| 2019 | -174.68 Million USD | -50.74% |
| 2018 | -115.88 Million USD | -65.9% |
| 2017 | -69.85 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -138.37 Million USD | -111.99% |
| 2024 Q3 | -213.71 Million USD | -54.44% |
| 2024 Q1 | -65.27 Million USD | 43.71% |
| 2023 Q2 | -194.77 Million USD | -38.18% |
| 2023 FY | -615.06 Million USD | -219.24% |
| 2023 Q4 | -115.97 Million USD | 29.03% |
| 2023 Q3 | -163.41 Million USD | 16.1% |
| 2023 Q1 | -140.95 Million USD | -38.73% |
| 2022 Q3 | 175.31 Million USD | 329.19% |
| 2022 Q2 | -76.49 Million USD | -114.75% |
| 2022 Q1 | 518.62 Million USD | -1.26% |
| 2022 FY | 515.83 Million USD | -2.41% |
| 2022 Q4 | -101.6 Million USD | -157.96% |
| 2021 FY | 528.58 Million USD | 276.98% |
| 2021 Q4 | 525.25 Million USD | 375.65% |
| 2021 Q3 | 110.42 Million USD | 78.65% |
| 2021 Q2 | 61.81 Million USD | 136.6% |
| 2021 Q1 | -168.91 Million USD | -59.88% |
| 2020 Q3 | -84.6 Million USD | -171.47% |
| 2020 Q2 | -31.16 Million USD | 59.65% |
| 2020 FY | -298.66 Million USD | -70.98% |
| 2020 Q1 | -77.24 Million USD | -21.12% |
| 2020 Q4 | -105.64 Million USD | -24.87% |
| 2019 Q3 | -48.31 Million USD | -42.4% |
| 2019 FY | -174.68 Million USD | -50.74% |
| 2019 Q1 | -28.67 Million USD | -8.63% |
| 2019 Q4 | -63.77 Million USD | -31.99% |
| 2019 Q2 | -33.92 Million USD | -18.34% |
| 2018 Q4 | -26.39 Million USD | 21.11% |
| 2018 Q1 | -28.01 Million USD | 0.0% |
| 2018 FY | -115.88 Million USD | -65.9% |
| 2018 Q2 | -28.01 Million USD | 0.0% |
| 2018 Q3 | -33.45 Million USD | -19.41% |
| 2017 FY | -69.85 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -102.07 Million USD | -502.587% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -3132.25% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1650.316% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -1104.632% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -205.102% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -364.222% |
| Agenus Inc. | -245.76 Million USD | -150.268% |
| Fortress Biotech, Inc. | -60.63 Million USD | -914.333% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1566.858% |
| Novavax, Inc. | -545.06 Million USD | -12.842% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -302.022% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -65611.645% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -526.673% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -9100.613% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -1084.518% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -39.71% |
| AlloVir, Inc. | -190.41 Million USD | -223.006% |
| Aptorum Group Limited | -2.82 Million USD | -21674.792% |
| Ardelyx, Inc. | -66.06 Million USD | -830.966% |
| Bicycle Therapeutics plc | -180.66 Million USD | -240.445% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -243.508% |
| Chimerix, Inc. | -82.09 Million USD | -649.206% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1278.958% |
| CRISPR Therapeutics AG | -153.61 Million USD | -300.404% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1793.369% |
| Precision BioSciences, Inc. | -61.31 Million USD | -903.051% |
| Dyadic International, Inc. | -6.79 Million USD | -8951.056% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1245.749% |
| Fortress Biotech, Inc. | -60.63 Million USD | -914.333% |
| GT Biopharma, Inc. | -7.59 Million USD | -7996.104% |
| Alkermes plc | 355.75 Million USD | 272.888% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3887.159% |
| Innoviva, Inc. | 179.72 Million USD | 442.229% |
| IO Biotech, Inc. | -86.08 Million USD | -614.498% |
| Jaguar Health, Inc. | -41.3 Million USD | -1389.252% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1279.317% |
| ContextLogic Inc. | -317 Million USD | -94.026% |
| AbCellera Biologics Inc. | -146.39 Million USD | -320.129% |
| Lantern Pharma Inc. | -15.96 Million USD | -3753.395% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -7135.161% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -199.628% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -64.618% |
| MEI Pharma, Inc. | 17.77 Million USD | 3559.675% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -738.563% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2427.029% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -334.964% |
| NextCure, Inc. | -62.72 Million USD | -880.599% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -653.936% |
| ChromaDex Corporation | -4.93 Million USD | -12355.67% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -444.49% |
| Incyte Corporation | 597.59 Million USD | 202.922% |
| Opthea Limited | -220.24 Million USD | -179.266% |
| MiMedx Group, Inc. | 67.43 Million USD | 1012.026% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -942.783% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -835.241% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -1102.253% |
| Vaxcyte, Inc. | -402.26 Million USD | -52.899% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1332.3% |
| Pharming Group N.V. | -10.54 Million USD | -5731.068% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2406.055% |
| Onconetix, Inc. | -37.4 Million USD | -1544.122% |
| Acelyrin, Inc. | -381.64 Million USD | -61.162% |
| PureTech Health plc | -65.69 Million USD | -836.209% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -733.529% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -189.822% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -3216.391% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2427.029% |
| ESSA Pharma Inc. | -26.58 Million USD | -2213.795% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2351.321% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -6059.233% |
| Seer, Inc. | -86.27 Million USD | -612.891% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -138.552% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1547.191% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -2158.099% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4903640.745% |
| Summit Therapeutics Inc. | -614.92 Million USD | -0.022% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1703.645% |
| Senti Biosciences, Inc. | -92.91 Million USD | -561.932% |
| ImmuCell Corporation | -5.77 Million USD | -10551.148% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -273.729% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -955.12% |
| Precigen, Inc. | -95.9 Million USD | -541.33% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -1030.17% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1457.945% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -487.456% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -887.97% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -4605.228% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | -7.37% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -818.07% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1994.752% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -2061.75% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2931.201% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -969.43% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -282.196% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -17042.168% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -154.83% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 961.309% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -1152.16% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -6082.918% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -150.437% |
| Aptose Biosciences Inc. | -51.2 Million USD | -1101.127% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -525.711% |
| Soligenix, Inc. | -6.14 Million USD | -9916.089% |
| Century Therapeutics, Inc. | -136.67 Million USD | -350.024% |
| Kura Oncology, Inc. | -152.63 Million USD | -302.973% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -589.391% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -5736.601% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 108869.873% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -107995.079% |
| Autolus Therapeutics plc | -208.38 Million USD | -195.159% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -755.463% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -768.792% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2738.568% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -173.057% |
| GRI Bio, Inc. | -13.03 Million USD | -4617.811% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -14776.028% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -395.681% |
| IGM Biosciences, Inc. | -246.41 Million USD | -149.603% |
| INmune Bio, Inc. | -30 Million USD | -1949.657% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -456.319% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1357.705% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3753.365% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3794.028% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -930.512% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -507.966% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -122.746% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -158.546% |
| Verastem, Inc. | -87.36 Million USD | -603.997% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -1035.05% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -281.23% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -427.234% |
| Histogen Inc. | -10.62 Million USD | -5690.99% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -4205.113% |
| Surrozen, Inc. | -43.04 Million USD | -1328.979% |
| Organovo Holdings, Inc. | -14.67 Million USD | -4092.359% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -11990.77% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -1075.149% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -2334.632% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -2183.247% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -7259.754% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -307.096% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -1157.124% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1969.171% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -5803.998% |
| Apollomics, Inc. | -172.6 Million USD | -256.348% |
| Amarin Corporation plc | -59.11 Million USD | -940.501% |
| Mesoblast Limited | -87.95 Million USD | -599.283% |
| Turnstone Biologics Corp. | -55.2 Million USD | -1014.241% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -318.517% |
| Synaptogenix, Inc. | -6.03 Million USD | -10085.652% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3694.799% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -688.338% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12736.593% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -7220.241% |
| Exelixis, Inc. | 207.76 Million USD | 396.037% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1446.934% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -327.28% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -16.35% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4953.069% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -7790.769% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1900.263% |
| Gritstone bio, Inc. | -138.49 Million USD | -344.119% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -854.101% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -15276.717% |
| Avid Bioservices, Inc. | -140.75 Million USD | -336.979% |
| Insmed Incorporated | -749.56 Million USD | 17.944% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3949.249% |
| MediWound Ltd. | -6.71 Million USD | -9058.145% |
| OmniAb, Inc. | -50.61 Million USD | -1115.079% |
| Alector, Inc. | -130.39 Million USD | -371.705% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -440.837% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -1086.3% |
| Zai Lab Limited | -334.62 Million USD | -83.809% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -89.842% |
| Aura Biosciences, Inc. | -76.4 Million USD | -704.969% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -162.139% |
| Immunic, Inc. | -93.61 Million USD | -557.032% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -352.607% |
| Veracyte, Inc. | -74.4 Million USD | -726.65% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -7913.25% |
| FibroGen, Inc. | -284.23 Million USD | -116.394% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2244.697% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -8684.214% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -3165.921% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 248.267% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2626.939% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1348.323% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4953.701% |
| Galecto, Inc. | -38.34 Million USD | -1503.851% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -3160.156% |
| Fortrea Holdings Inc. | -3.4 Million USD | -17990.029% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -385.661% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -3432.6% |
| XBiotech Inc. | -24.55 Million USD | -2404.626% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -854.101% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -881.272% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -524.897% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2770.495% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -1014.382% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | -1.388% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -801.122% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -1080205.266% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -171.503% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2662.144% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -179.942% |
| NexImmune, Inc. | -32.34 Million USD | -1801.6% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -11534.397% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -4278.938% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 115.557% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2439.371% |
| Scopus BioPharma Inc. | -11.6 Million USD | -5197.762% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -426.602% |
| Ainos, Inc. | -13.77 Million USD | -4366.496% |
| Pluri Inc. | -20.88 Million USD | -2844.566% |
| Prothena Corporation plc | -147.02 Million USD | -318.329% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -440.138% |
| Celularity Inc. | -196.29 Million USD | -213.335% |
| Rallybio Corporation | -74.56 Million USD | -724.877% |
| Cue Biopharma, Inc. | -50.73 Million USD | -1112.349% |
| MeiraGTx Holdings plc | -84.02 Million USD | -631.98% |
| Omeros Corporation | -117.81 Million USD | -422.065% |
| Humacyte, Inc. | -110.77 Million USD | -455.229% |
| Immunocore Holdings plc | -55.28 Million USD | -1012.488% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -3320.046% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2582.225% |
| Blueprint Medicines Corporation | -506.98 Million USD | -21.318% |
| CalciMedica, Inc. | -34.35 Million USD | -1690.206% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -808.845% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -270.99% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -117.14% |
| Pulmatrix, Inc. | -14.12 Million USD | -4255.648% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1647.581% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -644.284% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -27.82% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -486.493% |
| Cytokinetics, Incorporated | -526.24 Million USD | -16.878% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1605.424% |
| Nutriband Inc. | -5.48 Million USD | -11112.868% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1421.675% |
| Vor Biopharma Inc. | -117.86 Million USD | -421.844% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 114.143% |
| Evogene Ltd. | -23.87 Million USD | -2475.74% |
| ProKidney Corp. | -35.46 Million USD | -1634.129% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -413.565% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -7739.776% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 4.375% |
| CorMedix Inc. | -46.33 Million USD | -1227.301% |
| BioLineRx Ltd. | -60.61 Million USD | -914.718% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -504.518% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1397.738% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1429.09% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -662.628% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -714.424% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -110.5% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -2106.418% |
| MediciNova, Inc. | -8.57 Million USD | -7075.638% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -398.926% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -7242.404% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2268.647% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -157.092% |
| Biomea Fusion, Inc. | -117.25 Million USD | -424.55% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 1.842% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1987.358% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -301.575% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -193.782% |
| Absci Corporation | -110.56 Million USD | -456.284% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1940.003% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -509.956% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -160.689% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 4467.09% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -218.747% |
| Allakos Inc. | -185.7 Million USD | -231.21% |
| Imunon, Inc. | -19.51 Million USD | -3051.738% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -531.901% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 679.481% |
| BioAtla, Inc. | -123.46 Million USD | -398.178% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4953.069% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3725.482% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -87.94% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1564.622% |
| XOMA Corporation | -40.83 Million USD | -1406.358% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -503.77% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -418.982% |
| aTyr Pharma, Inc. | -50.38 Million USD | -1120.626% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -601.492% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -305.288% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -158.718% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1651.363% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -7500.909% |
| Akari Therapeutics, Plc | -10 Million USD | -6045.693% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -913469.996% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 318.421% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -9128.362% |
| UroGen Pharma Ltd. | -102.24 Million USD | -501.562% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -475.938% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -7808.531% |
| Orgenesis Inc. | -55.36 Million USD | -1011.001% |
| Entera Bio Ltd. | -8.88 Million USD | -6819.35% |
| GH Research PLC | -35.58 Million USD | -1628.331% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2851.348% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -694.776% |
| Xencor, Inc. | -126.08 Million USD | -387.807% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -16233.236% |
| Replimune Group, Inc. | -215.79 Million USD | -185.022% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2792.154% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 24614.189% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -9128.362% |
| Portage Biotech Inc. | -75.33 Million USD | -716.391% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -7242.404% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -536.347% |
| OncoCyte Corporation | -27.78 Million USD | -2113.963% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -4484.119% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -5430.368% |
| Purple Biotech Ltd. | -19.88 Million USD | -2993.868% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -8662.801% |
| scPharmaceuticals Inc. | -54.81 Million USD | -1022.169% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -3413.401% |
| HilleVax, Inc. | -123.56 Million USD | -397.759% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -5985.495% |
| Tharimmune, Inc. | -9.31 Million USD | -6500.009% |
| Genprex, Inc. | -30.86 Million USD | -1893.039% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -160.702% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1943.799% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -34415.208% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -11513.657% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3655437.501% |
| Savara Inc. | -54.69 Million USD | -1024.467% |
| Curis, Inc. | -47.41 Million USD | -1197.241% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1939.233% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3882.244% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -10944.371% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1962.925% |
| BeiGene, Ltd. | -881.7 Million USD | 30.242% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2788.424% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -40.95% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -679.002% |
| Erasca, Inc. | -125.04 Million USD | -391.884% |
| bluebird bio, Inc. | -211.91 Million USD | -190.242% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -12199.997% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 466.883% |
| DBV Technologies S.A. | -72.72 Million USD | -745.724% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -12199.997% |
| Moderna, Inc. | -4.71 Billion USD | 86.952% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1431.641% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -10701.914% |
| Molecular Templates, Inc. | -8.12 Million USD | -7470.913% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -918.515% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -452.124% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -354.416% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1183.543% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -334.89% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -219.662% |
| MacroGenics, Inc. | -9.05 Million USD | -6690.252% |
| RenovoRx, Inc. | -10.23 Million USD | -5911.151% |
| Adicet Bio, Inc. | -142.65 Million USD | -331.144% |
| Prime Medicine, Inc. | -198.13 Million USD | -210.428% |
| Aditxt, Inc. | -32.38 Million USD | -1799.46% |
| Adagene Inc. | -18.94 Million USD | -3146.326% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8311.984% |
| Quantum-Si incorporated | -95.96 Million USD | -540.956% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -416.732% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -4119.171% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 564.793% |
| SciSparc Ltd. | -5.12 Million USD | -11908.219% |
| Vericel Corporation | -3.18 Million USD | -19229.384% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -511368.226% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1949.838% |
| Generation Bio Co. | -126.61 Million USD | -385.784% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -743.809% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -646.053% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -134.631% |
| Invivyd, Inc. | -198.64 Million USD | -209.631% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -79.857% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -6980.594% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2796.926% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -6129.097% |
| 2seventy bio, Inc. | -217.57 Million USD | -182.696% |
| ADMA Biologics, Inc. | -28.23 Million USD | -2078.055% |
| Clene Inc. | -49.5 Million USD | -1142.447% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2659.663% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -1144.206% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2268.647% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -87.481% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1790.0% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2807.135% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -522.583% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -722.78% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -282.489% |
| Evaxion Biotech A/S | -22.12 Million USD | -2679.937% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -661.818% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -207.426% |
| Trevena, Inc. | -40.28 Million USD | -1426.623% |
| Surrozen, Inc. | -43.04 Million USD | -1328.979% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -789.665% |
| Cingulate Inc. | -23.53 Million USD | -2513.394% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -8798.452% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1443.053% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -7876.749% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -581.81% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -903.591% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -933.664% |
| Clearmind Medicine Inc. | -11.95 Million USD | -5044.788% |
| Kronos Bio, Inc. | -112.67 Million USD | -445.881% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -788.855% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -24250894.586% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -616.061% |
| Statera Biopharma, Inc. | -174.4 Million USD | -252.656% |
| ImmunityBio, Inc. | -583.19 Million USD | -5.464% |
| Korro Bio, Inc. | -81.17 Million USD | -657.726% |
| Kineta, Inc. | -14.09 Million USD | -4262.444% |
| BioVie Inc. | -32.12 Million USD | -1814.853% |
| Codexis, Inc. | -76.24 Million USD | -706.743% |
| Celularity Inc. | -196.29 Million USD | -213.335% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -186.703% |
| Celcuity Inc. | -63.77 Million USD | -864.361% |
| Virax Biolabs Group Limited | -6.73 Million USD | -9034.293% |
| Cibus, Inc. | -267.62 Million USD | -129.82% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1425.222% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1617.52% |
| IN8bio, Inc. | -30 Million USD | -1949.725% |
| Kodiak Sciences Inc. | -260.49 Million USD | -136.116% |
| Annexon, Inc. | -134.23 Million USD | -358.19% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -424.953% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -904.542% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1849.851% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -67.918% |
| Eyenovia, Inc. | -27.26 Million USD | -2156.186% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2948.692% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -114864.673% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -705.012% |
| Arcellx, Inc. | -70.69 Million USD | -770.082% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1384.185% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -359.632% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1947.678% |
| Moolec Science SA | -51.78 Million USD | -1087.631% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -1074.431% |
| Geron Corporation | -184.12 Million USD | -234.042% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1365.338% |
| Royalty Pharma plc | 1.13 Billion USD | 154.198% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -352.397% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -6817.169% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2795.327% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -258.281% |
| Humacyte, Inc. | -110.77 Million USD | -455.229% |
| Structure Therapeutics Inc. | -89.62 Million USD | -586.299% |
| 89bio, Inc. | -142.18 Million USD | -332.566% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -791.91% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -5827.156% |
| Genelux Corporation | -28.29 Million USD | -2073.591% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -2016.157% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -247.259% |
| Notable Labs, Ltd. | -11.26 Million USD | -5360.414% |
| Liquidia Corporation | -78.5 Million USD | -683.497% |
| Mustang Bio, Inc. | -51.6 Million USD | -1091.932% |
| Immunovant, Inc. | -259.33 Million USD | -137.168% |
| Quantum-Si incorporated | -95.96 Million USD | -540.956% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -744.296% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -3073.526% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -540.755% |
| Acasti Pharma Inc. | -12.85 Million USD | -4685.35% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2638.734% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3753.365% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -237.217% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -14198.7% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4832.326% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1985.589% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1477.565% |
| PepGen Inc. | -78.62 Million USD | -682.262% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1966.112% |
| United Therapeutics Corporation | 984.8 Million USD | 162.455% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2663.077% |
| Solid Biosciences Inc. | -96.01 Million USD | -540.588% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12736.593% |
| Immuneering Corporation | -53.47 Million USD | -1050.257% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -11990.77% |
| Silo Pharma, Inc. | -3.7 Million USD | -16520.202% |
| Belite Bio, Inc | -31.63 Million USD | -1844.427% |
| XOMA Corporation | -40.83 Million USD | -1406.358% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -1031.355% |
| Bionomics Limited | -15.49 Billion USD | 96.03% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -632.346% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2009.48% |
| uniQure N.V. | -308.47 Million USD | -99.386% |
| Cassava Sciences, Inc. | -97.21 Million USD | -532.668% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8311.984% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -398.308% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1854.063% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -7399.186% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -2015.938% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -114864.673% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2244.697% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3631.034% |
| Altimmune, Inc. | -88.44 Million USD | -595.401% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -305.756% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2009.48% |
| Compugen Ltd. | -18.75 Million USD | -3179.626% |
| Peak Bio, Inc. | -1259.26 USD | -48842950.681% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1235.666% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2727.737% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -81.546% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -641.448% |
| Zura Bio Limited | -60.36 Million USD | -918.988% |
| PolyPid Ltd. | -23.86 Million USD | -2477.251% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3809.617% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -641.448% |
| Instil Bio, Inc. | -156.08 Million USD | -294.05% |
| argenx SE | -295.05 Million USD | -108.458% |
| Immunome, Inc. | -106.8 Million USD | -475.867% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1347.407% |
| Verona Pharma plc | -54.36 Million USD | -1031.271% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -515.572% |
| Shattuck Labs, Inc. | -87.29 Million USD | -604.553% |
| CervoMed Inc. | -2.17 Million USD | -28219.381% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -393.426% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -4518.962% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1312.148% |
| Moolec Science SA | -51.78 Million USD | -1087.631% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3556866.249% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -355.205% |
| AnaptysBio, Inc. | -163.61 Million USD | -275.91% |
| Design Therapeutics, Inc. | -66.86 Million USD | -819.896% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -655.473% |
| NeurAxis, Inc. | -14.62 Million USD | -4105.061% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1523.623% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1707.196% |
| Achilles Therapeutics plc | -69.66 Million USD | -782.884% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -515.572% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2985.315% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 20542.138% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -24250894.586% |
| Nutriband Inc. | -5.48 Million USD | -11112.868% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -510.804% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1165.375% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -697.838% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1710.601% |
| MoonLake Immunotherapeutics | -36 Million USD | -1608.158% |
| Palisade Bio, Inc. | -12.3 Million USD | -4900.496% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1360.12% |
| Beam Therapeutics Inc. | -132.52 Million USD | -364.102% |
| Neurogene Inc. | -36.31 Million USD | -1593.59% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -276.38% |
| AEON Biopharma, Inc. | -52.55 Million USD | -1070.296% |
| Sesen Bio, Inc. | -19.88 Million USD | -2993.246% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -759.216% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4815.024% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -38.516% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -451.298% |
| Athira Pharma, Inc. | -117.67 Million USD | -422.691% |
| Vaccinex, Inc. | -20.25 Million USD | -2937.188% |
| HCW Biologics Inc. | -24.99 Million USD | -2360.807% |
| XOMA Corporation | -40.83 Million USD | -1406.358% |
| Nektar Therapeutics | -276.05 Million USD | -122.803% |
| Arvinas, Inc. | -367.3 Million USD | -67.455% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -913469.996% |
| Merus N.V. | -154.93 Million USD | -296.97% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -531.298% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1859.729% |
| Rezolute, Inc. | -68.45 Million USD | -798.437% |
| Clene Inc. | -49.5 Million USD | -1142.447% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3887.825% |
| BeyondSpring Inc. | -21.02 Million USD | -2825.24% |
| Synlogic, Inc. | -57.28 Million USD | -973.742% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -5068.146% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5581.332% |
| Peak Bio, Inc. | -1259.26 USD | -48842950.681% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1545.956% |
| Krystal Biotech, Inc. | 10.93 Million USD | 5726.244% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -329.815% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -89.189% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -13215.992% |
| MannKind Corporation | -11.93 Million USD | -5052.128% |
| Ikena Oncology, Inc. | -68.16 Million USD | -802.299% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2826.771% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -561.833% |
| Gossamer Bio, Inc. | -179.81 Million USD | -242.048% |
| CohBar, Inc. | -11.96 Million USD | -5041.74% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -2285.067% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1940.003% |
| Legend Biotech Corporation | -518.25 Million USD | -18.679% |
| Mural Oncology plc | -207.44 Million USD | -196.491% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -395.557% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -3262.877% |
| Disc Medicine, Inc. | -76.42 Million USD | -704.748% |
| Champions Oncology, Inc. | -7.27 Million USD | -8353.285% |
| REGENXBIO Inc. | -263.49 Million USD | -133.425% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -5695.314% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1194.729% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1519.285% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -514.06% |
| Vaxart, Inc. | -82.46 Million USD | -645.845% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 184380.762% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1538.305% |
| Cellectis S.A. | -101.05 Million USD | -508.616% |
| Longeveron Inc. | -21.41 Million USD | -2772.372% |
| Repare Therapeutics Inc. | -93.79 Million USD | -555.743% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -14.755% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -764.226% |
| Revolution Medicines, Inc. | -436.36 Million USD | -40.95% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -9260.234% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1895.396% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -787.111% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -850.165% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -6169.096% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 116.993% |
| Denali Therapeutics Inc. | -145.22 Million USD | -323.526% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -511368.226% |
| Veru Inc. | -93.15 Million USD | -560.272% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -2175.56% |
| Cingulate Inc. | -23.53 Million USD | -2513.394% |
| Passage Bio, Inc. | -102.06 Million USD | -502.635% |
| Context Therapeutics Inc. | -23.96 Million USD | -2466.581% |
| Exicure, Inc. | -16.91 Million USD | -3536.402% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -225.572% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1528.697% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -9351.826% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -233.045% |
| Nuvalent, Inc. | -126.21 Million USD | -387.297% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -5749.003% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -607.951% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1913.688% |
| OmniAb, Inc. | -50.61 Million USD | -1115.079% |
| Anew Medical, Inc. | 1.34 Million USD | 45791.225% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3733.35% |
| Lipocine Inc. | -16.35 Million USD | -3661.362% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -826.38% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -865.938% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1357.705% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1182.259% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -3001.513% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -13.587% |
| Ocugen, Inc. | -63.07 Million USD | -875.08% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -542.482% |
| Q32 Bio Inc. | -112.96 Million USD | -444.49% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -3477.6% |
| Alumis Inc. Common Stock | -154.99 Million USD | -296.831% |
| Equillium, Inc. | -13.33 Million USD | -4512.381% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -918.886% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -7599.97% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -3162.711% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -941.029% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -437.045% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -3246.733% |
| Dominari Holdings Inc. | -22.88 Million USD | -2587.969% |
| Edesa Biotech, Inc. | -8.37 Million USD | -7244.525% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2937.338% |
| Bio-Techne Corporation | 168.1 Million USD | 465.879% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -74.69% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 577.335% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -404.844% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1521.184% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -446.032% |
| Nkarta, Inc. | -117.5 Million USD | -423.452% |
| BioCardia, Inc. | -11.57 Million USD | -5215.539% |
| Iterum Therapeutics plc | -38.37 Million USD | -1502.932% |